Stay updated on KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer
Sign up to get notified when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.
Latest updates to the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page
- Check3 days agoChange DetectedThe website has updated the intervention details, confirming the status as 'Recruiting' and revising the version to v2.14.0, while removing previous contact information and the earlier version v2.13.3.SummaryDifference1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference2%
- Check53 days agoChange DetectedSeveral key resources related to genetics and breast cancer have been removed, including links to MedlinePlus and PubMed articles, which may impact access to important health information.SummaryDifference3%
- Check60 days agoChange DetectedNew resources related to breast cancer and Pembrolizumab have been added, including links to MedlinePlus and PubMed, which may be of particular interest to users seeking updated medical information.SummaryDifference0.4%
- Check68 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference3%
Stay in the know with updates to KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer
Enter your email address, and we'll notify you when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.